‘Lost’ smear-positive pulmonary tuberculosis cases: where are they and why did we lose them?
OBJECTIVES: 1) To locate smear-positive pulmonary tuberculosis patients who were identified during the first 6 months of 2000 but did not start treatment (‘lost cases’); 2) to describe these patients' pathways to diagnosis, health status and socio-demographic characteristics; and 3) to explore why these patients did not start treatment.
METHODS: Lost cases were traced from programme registers and interviewed using the qualitative research critical incidents narrative (CIN) interviews technique. Results were triangulated with responses from health care workers through focus group discussions.
RESULTS: The laboratory registered 157 new smear-positive patients. Twenty three (15%) of these were ‘lost’ (did not appear in the treatment register). CIN interviews were conducted with five lost patients and 14 carers of lost patients who had died. Long pathways to diagnosis were the norm. Health system structural barriers were the main factors behind these pathways, including requirement for hospital attendance, delays in symptom recognition and receipt of sputum results, and the misconception that negative smears excluded tuberculosis.
CONCLUSION: Some smear-positive cases experience very long pathways to diagnosis and are lost from this free public health system. The diagnostic process needs to become more responsive to patients' needs.
Document Type: Regular Paper
Affiliations: 1: Clinical Research Group, Liverpool School of Tropical Medicine, Liverpool, United Kingdom 2: International Health Research Group, Liverpool School of Tropical Medicine, Liverpool, United Kingdom 3: Ministry of Health & Population, Ntcheu District Hospital, Ntcheu, Malawi 4: Community Health Sciences Unit, National TB Control Programme, Lilongwe, Malawi
Publication date: 2005-01-01
The International Journal of Tuberculosis and Lung Disease publishes articles on all aspects of lung health, including public health-related issues such as training programmes, cost-benefit analysis, legislation, epidemiology, intervention studies and health systems research. The IJTLD is dedicated to the continuing education of physicians and health personnel and the dissemination of information on tuberculosis and lung health world-wide.
Certain IJTLD articles are selected for translation into French, Spanish, Chinese or Russian. They are available on the Union website
- Editorial Board
- Information for Authors
- Subscribe to this Title
- International Journal of Tuberculosis and Lung Disease
- Public Health Action
- Ingenta Connect is not responsible for the content or availability of external websites